ARTICLE | Clinical News
Angeliq estradiol/drospirenone regulatory update
September 20, 2004 7:00 AM UTC
SHR subsidiary Berlex Laboratories (Montville, N.J.) received an FDA approvable letter for Angeliq tablets, a once-daily hormone replacement therapy (HRT), to treat menopausal symptoms. Berlex said FD...